About Jeffrey Arnold
Form D filings for Xeno Biosciences from 2021 to 2023 list Jeffrey Arnold as director.
Jeffrey Arnold first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jeffrey Arnold in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jeffrey Arnold works with at each company, as listed on that company's latest Form D.
Xeno Biosciences Inc. · Form D, Jan 5, 2023
DB
David Beno
Chief Executive Officer and director
MK
Michael Koeris
Director
TH
Tom Hughes
Director
SR
Stan Rose
Director